Can a pneumothorax cause an elevation of cardiac troponin I?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Pneumothorax Elevate Troponin I?

Yes, pneumothorax can cause troponin I elevation, though this represents myocardial injury rather than acute coronary syndrome and should not be automatically assumed to indicate myocardial infarction.

Clinical Context and Mechanism

Pneumothorax is explicitly recognized in major cardiology guidelines as a non-ACS condition that must be considered when evaluating patients with elevated troponin 1. The 2014 AHA/ACC guidelines specifically list "acute pulmonary thromboembolic disease" and other severe noncardiac conditions among causes of troponin elevation 2. While pneumothorax itself is not directly listed in every guideline's table of non-ACS causes, it appears in the differential diagnosis tables for suspected ACS 1.

The mechanism likely involves:

  • Acute right ventricular strain from tension physiology
  • Hypoxemia causing myocardial stress
  • Hemodynamic compromise with hypotension
  • Increased myocardial oxygen demand in the setting of reduced supply

A case report documented ECG changes with elevated troponin I in an 86-year-old patient with tension pneumothorax, with normalization after resolution 3.

Diagnostic Approach

When encountering elevated troponin in a patient with pneumothorax, you must determine whether this represents:

  1. Type 2 MI (supply-demand mismatch from the pneumothorax itself)
  2. Acute myocardial injury (non-ischemic cardiomyocyte damage)
  3. Type 1 MI (coincidental plaque rupture triggered by the acute stress)

Key Distinguishing Features:

Look for a rise and/or fall pattern: The universal definition of MI requires detection of a rise and/or fall of cardiac biomarkers with at least one value above the 99th percentile, PLUS one of the following 1:

  • Symptoms consistent with ischemia
  • ECG changes indicative of new ischemia or new pathological Q waves
  • Imaging evidence of new loss of viable myocardium or new regional wall motion abnormalities

Magnitude matters but doesn't distinguish causes: Troponin concentrations at presentation are insufficient to distinguish type 1 MI from other causes of myocardial injury in practice 4. However, the kinetics provide important clues - type 1 MI typically shows higher absolute and relative changes in troponin concentration 4.

Serial measurements are mandatory: A single elevated troponin is diagnostically inadequate. Repeat testing at 3-6 hour intervals is essential 2. If the initial troponin is below the reference threshold, repeat at 6 hours 1.

Clinical Pitfalls to Avoid

Do not assume elevated troponin = ACS: Solitary elevations of troponin cannot be assumed to be due to MI, as troponin elevations can occur from tachyarrhythmia, hypotension or hypertension, cardiac trauma, acute heart failure, myocarditis and pericarditis, acute pulmonary thromboembolic disease, and severe noncardiac conditions such as sepsis, burns, respiratory failure, and acute neurological diseases 2.

Context is critical: The 2011 Canadian guidelines emphasize that "troponin is a highly specific and sensitive marker of myocardial cell injury, but is not a specific marker for plaque rupture, erosion, and/or ulceration and thrombosis precipitating ACS" 1.

Clinical correlation is mandatory: In the diagnosis of NSTEMI, cardiac troponin values must manifest an acute pattern consistent with the clinical events, including ischemic symptoms and electrocardiographic changes 2.

Management Implications

For pneumothorax with elevated troponin:

  • Treat the pneumothorax definitively (chest tube decompression if tension physiology)
  • Obtain serial troponins to assess kinetics
  • Perform ECG looking for ischemic changes (not just nonspecific changes from pneumothorax)
  • Consider echocardiography if troponin is markedly elevated (>5x upper reference limit) to assess for regional wall motion abnormalities 5
  • Reserve invasive coronary evaluation for patients with clear evidence of type 1 MI (ischemic symptoms, ECG changes, or imaging evidence of new myocardial damage)

Prognostic significance: Even when troponin elevation is due to non-ACS causes, there is often substantial risk of adverse outcomes, as troponin elevation indicates cardiomyocyte necrosis 2. These patients warrant appropriate follow-up and risk factor modification, though not necessarily acute invasive management.

The key is integrating the entire clinical picture rather than reflexively pursuing coronary angiography for every elevated troponin in the setting of acute pulmonary pathology.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.